Matches in Nanopublications for { ?s ?p "[Adenocarcinoma of the lung with EML4-ALK translocation is a rare subtype of Non Small-Cell Lung Cancer (NSCLC) that has recently shown to benefit from treatment with crizotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[Adenocarcinoma of the lung with EML4-ALK translocation is a rare subtype of Non Small-Cell Lung Cancer (NSCLC) that has recently shown to benefit from treatment with crizotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Adenocarcinoma of the lung with EML4-ALK translocation is a rare subtype of Non Small-Cell Lung Cancer (NSCLC) that has recently shown to benefit from treatment with crizotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Adenocarcinoma of the lung with EML4-ALK translocation is a rare subtype of Non Small-Cell Lung Cancer (NSCLC) that has recently shown to benefit from treatment with crizotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1215950.RARsLzMZMhHu0PkUNNs55jF4_Q47IzSLqgRPrUFT80DDE130_assertion description "[Adenocarcinoma of the lung with EML4-ALK translocation is a rare subtype of Non Small-Cell Lung Cancer (NSCLC) that has recently shown to benefit from treatment with crizotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215950.RARsLzMZMhHu0PkUNNs55jF4_Q47IzSLqgRPrUFT80DDE130_provenance.
- NP1215952.RA9cywYnikof3Ooh_6evHixvKlwIRrl_gizneallquOdc130_assertion description "[Adenocarcinoma of the lung with EML4-ALK translocation is a rare subtype of Non Small-Cell Lung Cancer (NSCLC) that has recently shown to benefit from treatment with crizotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215952.RA9cywYnikof3Ooh_6evHixvKlwIRrl_gizneallquOdc130_provenance.